Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review
Human Psychopharmacology: Clinical and Experimental · 2024
DOI: 10.1002/hup.2910 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2024. Verfasst von Wolfgang Kämmerer. Beteiligte Einrichtung: Medical Faculty, University of Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Dextroamphetamine, Lisdexamfetamine Dimesylate. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To compare the pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine (LDX).
Methods
A search of Medline and Embase was conducted to identify relevant articles for this literature review.
Results
Dexamphetamine and LDX, a prodrug of dexamphetamine, are indicated for the treatment of attention‐deficit/hyperactivity disorder. It has been suggested that LDX may have a reduced potential for oral abuse compared to immediate‐release dexamphetamine. As a prodrug, LDX has the same pharmacodynamic properties as dexamphetamine. A study in healthy adults showed that the pharmacokinetic profile of dexamphetamine following oral administration of LDX is essentially identical to that of an equimolar dose of dexamphetamine administered 1 h later. In addition, dexamphetamine produced subjective drug liking effects comparable to those produced by LDX. LDX showed linear dose proportional pharmacokinetics up to a dose of 250 mg, indicating a lack of overdose protection at supratherapeutic doses. Furthermore, the exposure to dexamphetamine released from LDX may be prolonged by the consumption of alkalizing agents.
Conclusions
The available evidence from pharmacodynamic, pharmacokinetic and abuse liability studies suggests a comparable potential for oral abuse of dexamphetamine and LDX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Faculty, University of Augsburg, Augsburg, Germany.
Zitieren
APA
Kämmerer, W. (2024). Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2910
Vancouver
Kämmerer W. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review. Human Psychopharmacology: Clinical and Experimental. 2024. doi:10.1002/hup.2910
BibTeX
@article{Kmmerer2024,
author = {Kämmerer, Wolfgang},
title = {Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2024},
doi = {10.1002/hup.2910}
}
EUVIMED